OBJECTIVE: Few studies have examined ankylosing spondylitis (AS) patients' concerns about and perceptions of biologic therapies, apart from traditional surveys. In this study, we used social media data to examine the knowledge, attitudes, and beliefs of AS patients regarding biologic therapies. METHODS: We collected posts published on 601 social media sites between January 1, 2016 and April 26, 2017. In each post, both an AS keyword and a biologic were mentioned. To explore themes within the collection of posts in an unsupervised manner, a latent Dirichlet allocation topic model was fit to the data set. Each discovered topic was represented as a discrete distribution over the words in the collection, similar to a word cloud. The topics were manually reviewed to identify themes, which were confirmed using thematic data analysis. RESULTS: We examined 27,416 social media posts and identified 112 themes. The majority of themes (n = 67 [60%]) focused on discussions related to AS treatment. Other themes, including the psychological impact of AS, reporting of medical literature, and AS disease consequences, accounted for the remaining 40% (n = 45). In discussions regarding AS treatment, most topics involved biologics, and most subthemes involved side effects (e.g., fatigue, allergic reactions), biologic treatment attributes (e.g., dosing, frequency), and concerns about use of biologics (e.g., increased cancer risk). Additional implicit patient needs (e.g., support) were identified using qualitative analyses. CONCLUSION: Social media revealed a dynamic range of themes governing AS patients' experience with and choice of biologic agents. The complexity of selecting biologics from among many such agents and navigating their risk/benefit profiles suggests the merit of creating online tools tailored to support patients' decision-making with regard to biologic therapies for AS.
OBJECTIVE: Few studies have examined ankylosing spondylitis (AS) patients' concerns about and perceptions of biologic therapies, apart from traditional surveys. In this study, we used social media data to examine the knowledge, attitudes, and beliefs of AS patients regarding biologic therapies. METHODS: We collected posts published on 601 social media sites between January 1, 2016 and April 26, 2017. In each post, both an AS keyword and a biologic were mentioned. To explore themes within the collection of posts in an unsupervised manner, a latent Dirichlet allocation topic model was fit to the data set. Each discovered topic was represented as a discrete distribution over the words in the collection, similar to a word cloud. The topics were manually reviewed to identify themes, which were confirmed using thematic data analysis. RESULTS: We examined 27,416 social media posts and identified 112 themes. The majority of themes (n = 67 [60%]) focused on discussions related to AS treatment. Other themes, including the psychological impact of AS, reporting of medical literature, and AS disease consequences, accounted for the remaining 40% (n = 45). In discussions regarding AS treatment, most topics involved biologics, and most subthemes involved side effects (e.g., fatigue, allergic reactions), biologic treatment attributes (e.g., dosing, frequency), and concerns about use of biologics (e.g., increased cancer risk). Additional implicit patient needs (e.g., support) were identified using qualitative analyses. CONCLUSION: Social media revealed a dynamic range of themes governing AS patients' experience with and choice of biologic agents. The complexity of selecting biologics from among many such agents and navigating their risk/benefit profiles suggests the merit of creating online tools tailored to support patients' decision-making with regard to biologic therapies for AS.
Authors: Denis Poddubnyy; Martin Rudwaleit; Hildrun Haibel; Joachim Listing; Elisabeth Märker-Hermann; Henning Zeidler; Jürgen Braun; Joachim Sieper Journal: Ann Rheum Dis Date: 2011-05-27 Impact factor: 19.103
Authors: Morgan Langille; André Bernard; Chris Rodgers; Stephanie Hughes; Des Leddin; Sander Veldhuyzen van Zanten Journal: Clin Gastroenterol Hepatol Date: 2010-01-06 Impact factor: 11.382
Authors: A Overbeek; M H van den Berg; C W P M Hukkelhoven; L C Kremer; M M van den Heuvel-Eibrink; W J E Tissing; J J Loonen; A B Versluys; D Bresters; G J L Kaspers; C B Lambalk; F E van Leeuwen; E van Dulmen-den Broeder Journal: Hum Reprod Date: 2012-11-21 Impact factor: 6.918
Authors: Sander van der Marel; Marjolijn Duijvestein; James C Hardwick; Gijs R van den Brink; Roeland Veenendaal; Daniel W Hommes; Herma H Fidder Journal: Inflamm Bowel Dis Date: 2009-05-21 Impact factor: 5.325
Authors: Stephanie A Irving; James G Donahue; David K Shay; Tina L Ellis-Coyle; Edward A Belongia Journal: Vaccine Date: 2009-09-01 Impact factor: 3.641
Authors: Roxanne Cooksey; Sinead Brophy; Muhammad Jami Husain; Elizabeth Irvine; Helen Davies; Stefan Siebert Journal: BMC Musculoskelet Disord Date: 2012-12-10 Impact factor: 2.362
Authors: Daniela Weiss; Imke Nordhorn; Linda Tizek; Thomas Werfel; Alexander Zink; Tilo Biedermann; Stephan Traidl; Maximilian C Schielein Journal: Acta Derm Venereol Date: 2021-09-28 Impact factor: 3.875
Authors: Gabriela Gonzalez; Kristina Vaculik; Carine Khalil; Yuliya Zektser; Corey Arnold; Christopher V Almario; Brennan M R Spiegel; Jennifer T Anger Journal: J Urol Date: 2019-12-19 Impact factor: 7.600
Authors: William Benjamin Nowell; Kelly Gavigan; Theresa Hunter; William N Malatestinic; Rebecca J Bolce; Jeffrey R Lisse; Carol Himelein; Jeffrey R Curtis; Jessica A Walsh Journal: ACR Open Rheumatol Date: 2021-11-10
Authors: Gabriela Gonzalez; Kristina Vaculik; Carine Khalil; Yuliya Zektser; Corey Arnold; Christopher V Almario; Brennan Spiegel; Jennifer Anger Journal: J Med Internet Res Date: 2022-01-25 Impact factor: 5.428
Authors: Gabriela Gonzalez; Kristina Vaculik; Carine Khalil; Yuliya Zektser; Corey Arnold; Christopher V Almario; Brennan M R Spiegel; Jennifer T Anger Journal: Female Pelvic Med Reconstr Surg Date: 2021-02-01 Impact factor: 1.913
Authors: Woojin Joo; Christopher V Almario; Mariko Ishimori; Yujin Park; Alma Jusufagic; Benjamin Noah; Lianne S Gensler; R Swamy Venuturupalli; Jonathan Kay; Michael H Weisman; Brennan M R Spiegel Journal: ACR Open Rheumatol Date: 2020-06-09